TrialBritish journal of cancer2025

Alkaline phosphatase decline and pain response as predictors of overall survival benefit in patients treated with radium-223: a post hoc analysis of the REASSURE study.

Joe M O'Sullivan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.